ASSESS – Sponsored by Novartis

Active Study

A year-long randomized, rater and dose blinded study to compare the efficacy and safety of Fingolimod 0.25mg and 0.5mg administered orally once daily with Glatiramer acetate 20 mg administered subcutaneously once daily in patients with relapsing-remitting mutltiple sclerosis. For this study being conducted in our Fairfax, Va. office, we do an OCT and/or FA to rule out suspected macular edema.

Return to Other Studies